We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.86B
AUM Growth
+$246M
Cap. Flow
+$82.5M
Cap. Flow %
4.43%
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$12.5M
3
NVDA icon
NVIDIA
NVDA
+$7.63M
4
AMZN icon
Amazon
AMZN
+$5.14M
5
TSLA icon
Tesla
TSLA
+$4.94M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$3.11M
2
XOM icon
ExxonMobil
XOM
+$2.53M
3
IMGN
Immunogen Inc
IMGN
+$2.22M
4
CVX icon
Chevron
CVX
+$2.06M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$1.23M

Sector Composition

Rank Sector Weight
1 Technology 37.9%
2 Healthcare 15.37%
3 Consumer Discretionary 12.43%
4 Communication Services 8.94%
5 Energy 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UPS icon
201
United Parcel Service
UPS
$97.6B
$1.51M 0.08%
8,433
+638
+8% +$113K
BEAM icon
202
Beam Therapeutics
BEAM
$2.58B
$1.51M 0.08%
47,154
+7,447
+19% +$242K
PRTA icon
203
Prothena Corp
PRTA
$458M
$1.51M 0.08%
22,049
-4,482
-17% -$289K
DASH icon
204
DoorDash
DASH
$75.3B
$1.5M 0.08%
19,596
-30
-0.2% -$1.99K
F icon
205
Ford
F
$57.3B
$1.5M 0.08%
98,909
+33,101
+50% +$419K
APLS
206
DELISTED
Apellis Pharmaceuticals
APLS
$1.49M 0.08%
16,387
-5,307
-24% -$458K
IONS icon
207
Ionis Pharmaceuticals
IONS
$9.35B
$1.49M 0.08%
36,284
-125
-0.3% -$4.8K
ACAD icon
208
Acadia Pharmaceuticals
ACAD
$4.25B
$1.49M 0.08%
62,081
-660
-1% -$14.7K
NTRA icon
209
Natera
NTRA
$37.5B
$1.48M 0.08%
30,487
+7,645
+33% +$390K
UNP icon
210
Union Pacific
UNP
$183B
$1.48M 0.08%
7,248
+558
+8% +$111K
CYTK icon
211
Cytokinetics
CYTK
$11B
$1.48M 0.08%
45,432
+5,358
+13% +$198K
NVAX icon
212
Novavax
NVAX
$1.23B
$1.48M 0.08%
199,183
+9,542
+5% +$75K
WBA
213
DELISTED
Walgreens Boots Alliance
WBA
$1.48M 0.08%
51,792
+2,397
+5% +$78.1K
VIR icon
214
Vir Biotechnology
VIR
$1.47B
$1.47M 0.08%
60,009
+910
+2% +$22.9K
MPWR icon
215
Monolithic Power Systems
MPWR
$65.5B
$1.47M 0.08%
2,722
+471
+21% +$224K
ALNY icon
216
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.47M 0.08%
7,729
+959
+14% +$190K
KDNY
217
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.46M 0.08%
38,127
+4,203
+12% +$108K
NTLA icon
218
Intellia Therapeutics
NTLA
$1.5B
$1.46M 0.08%
35,869
-269
-0.7% -$10.9K
CRWD icon
219
CrowdStrike
CRWD
$187B
$1.46M 0.08%
39,740
+3,520
+10% +$123K
IRWD icon
220
Ironwood Pharmaceuticals
IRWD
$611M
$1.46M 0.08%
136,980
+15,485
+13% +$166K
PTCT icon
221
PTC Therapeutics
PTCT
$6.37B
$1.45M 0.08%
35,713
+6,392
+22% +$313K
INSM icon
222
Insmed
INSM
$23.2B
$1.45M 0.08%
68,515
-2,880
-4% -$54.6K
AKAM icon
223
Akamai
AKAM
$16.8B
$1.44M 0.08%
15,998
+222
+1% +$19K
PTGX icon
224
Protagonist Therapeutics
PTGX
$8.75B
$1.43M 0.08%
51,783
+22,983
+80% +$575K
RLAY icon
225
Relay Therapeutics
RLAY
$4.02B
$1.42M 0.08%
113,113
+30,802
+37% +$383K
7 8
9
10 11

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Profund Advisors held 1,158 positions worth $1.86B, up 15% from $1.62B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors deployed $82.5M of net new capital in Q2 2023, opening 69 new positions and adding to 498 existing holdings. Its largest new stake was Biomea Fusion: 24,713 shares worth $542K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $3.11M trimmed.

  • Profund Advisors's largest Q2 2023 buy was Biomea Fusion: 24,713 shares worth $542K.
  • Profund Advisors added most to Apple in Q2 2023, an estimated $12.9M increase.
  • Profund Advisors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $3.11M.
  • Profund Advisors fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 34% of its $1.86B portfolio in Q2 2023.
  • Profund Advisors opened 69 new positions and closed 91 in Q2 2023.
  • Profund Advisors's portfolio value rose 15% quarter-over-quarter to $1.86B.

Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.